EYA3 and pancreatic ductal adenocarcinoma: Circ-EYA3 is elevated in pancreatic ductal adenocarcinoma (PDAC) tissues and cells, and higher levels of circ-EYA3 are significantly associated with poorer prognosis in PDAC patients.